Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD

BACKGROUND: Budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler (BGF MDI) is a triple fixed-dose combination for COPD. The long-term safety of triple therapy for COPD has not been investigated in Japanese patients. In this 28-week extension study (NCT03262012), we investigated the lon...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Int J Chron Obstruct Pulmon Dis
Main Authors: Ichinose, Masakazu, Fukushima, Yasushi, Inoue, Yoshikazu, Hataji, Osamu, Ferguson, Gary T, Rabe, Klaus F, Hayashi, Nobuya, Okada, Hiroshi, Takikawa, Mami, Bourne, Eric, Ballal, Shaila, DeAngelis, Kiernan, Aurivillius, Magnus, Reisner, Colin, Dorinsky, Paul
Formato: Artigo
Idioma:Inglês
Publicado: Dove 2019
Assuntos:
Original Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6934178/
https://ncbi.nlm.nih.gov/pubmed/31920296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S220861
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares